These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 36154316)

  • 1. Drug-Coated Balloon Angioplasty for Carotid Artery In-Stent Restenosis: Case Series.
    Eljack A; Shih E; Meidan T; Lanfear A; Taha M; Sayfo S; Gable D; Potluri S
    J Endovasc Ther; 2024 Apr; 31(2):305-311. PubMed ID: 36154316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug-Coated Balloons for Treatment of Internal Carotid Artery Restenosis After Stenting: A Single-Center Mid-Term Outcome Study.
    Hajiyev K; Henkes H; Khanafer A; Bücke P; Hennersdorf F; Bäzner H; von Gottberg P
    Cardiovasc Intervent Radiol; 2024 Mar; 47(3):291-298. PubMed ID: 38326576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rotational Atherectomy Combined with Drug Coated-Balloons for in-Stent Restenosis.
    Allan M; Vickers D; Pitney M; Jepson N
    Cardiovasc Revasc Med; 2019 Jul; 20(7):559-562. PubMed ID: 30217627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laser atherectomy and drug-coated balloons for the treatment of femoropopliteal in-stent restenosis: 2-Year outcomes.
    Kokkinidis DG; Behan S; Jawaid O; Hossain P; Giannopoulos S; Singh GD; Laird JR; Valle JA; Waldo SW; Armstrong EJ
    Catheter Cardiovasc Interv; 2020 Feb; 95(3):439-446. PubMed ID: 31816169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiography and Optical Coherence Tomography Assessment of the Drug-Coated Balloon ESSENTIAL for the Treatment of In-Stent Restenosis.
    de la Torre Hernández JM; Garcia Camarero T; Lozano Ruiz-Poveda F; Urbano-Carrillo CA; Sánchez Pérez I; Cano-García M; Saez R; Andrés Morist A; Molina E; Pinar E; Torres A; Lezcano EJ; Gutierrez H; Arnold RJ; Zueco J
    Cardiovasc Revasc Med; 2020 Apr; 21(4):508-513. PubMed ID: 31401071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of 2 Different Drug-Coated Balloons in In-Stent Restenosis: The RESTORE ISR China Randomized Trial.
    Chen Y; Gao L; Qin Q; Chen S; Zhang J; Chen H; Wang L; Jin Z; Zheng Y; Zhang Z; Li H; Li X; Fu G; Chen L; Sun Z; Wang Y; Jin Q; Cao F; Guo J; Zhao Y; Guan C; Li W; Xu B;
    JACC Cardiovasc Interv; 2018 Dec; 11(23):2368-2377. PubMed ID: 30522665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neointimal Modification With Scoring Balloon and Efficacy of Drug-Coated Balloon Therapy in Patients With Restenosis in Drug-Eluting Coronary Stents: A Randomized Controlled Trial.
    Kufner S; Joner M; Schneider S; Tölg R; Zrenner B; Repp J; Starkmann A; Xhepa E; Ibrahim T; Cassese S; Fusaro M; Ott I; Hengstenberg C; Schunkert H; Abdel-Wahab M; Laugwitz KL; Kastrati A; Byrne RA;
    JACC Cardiovasc Interv; 2017 Jul; 10(13):1332-1340. PubMed ID: 28683939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-Eluting Balloon Angioplasty for In-Stent Restenosis Following Carotid Artery Stent Placement.
    Bhatia K; Akhtar IN; Akinci Y; Liaqat J; Siddiq F; Gomez CR; Qureshi AI
    J Neuroimaging; 2020 May; 30(3):267-275. PubMed ID: 32227677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-coated balloon angioplasty: predicting outcomes based on different patterns of drug-eluting stent restenosis.
    Wang X; Lu W; Wang X; Pan L; Fu W; Liu Q; Han Z; Sun G; Qin X; Li R; Zheng X; Shan Y; Qiu C
    Int J Cardiovasc Imaging; 2020 Feb; 36(2):171-178. PubMed ID: 31919705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug-eluting balloon angioplasty versus uncoated balloon angioplasty for the treatment of in-stent restenosis of the femoropopliteal arteries.
    Kayssi A; Al-Jundi W; Papia G; Kucey DS; Forbes T; Rajan DK; Neville R; Dueck AD
    Cochrane Database Syst Rev; 2019 Jan; 1(1):CD012510. PubMed ID: 30684445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Turbo-Power™ Laser Atherectomy Combined with Drug-coated Balloon Angioplasty is Associated with Improved One-Year Outcomes for the Treatment of Tosaka II and III Femoropopliteal In-stent Restenosis.
    Giannopoulos S; Kokkinidis DG; Jawaid O; Behan S; Hossain P; Alvandi B; Foley TR; Singh GD; Waldo SW; Armstrong EJ
    Cardiovasc Revasc Med; 2020 Jun; 21(6):771-778. PubMed ID: 31761634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of paclitaxel-coated balloon angioplasty and paclitaxel-eluting stent implantation for treatment of coronary in-stent restenosis in patients with stable coronary artery disease.
    Bonaventura K; Leber AW; Sohns C; Roser M; Boldt LH; Kleber FX; Haverkamp W; Dorenkamp M
    Clin Res Cardiol; 2012 Jul; 101(7):573-84. PubMed ID: 22350752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Superficial Femoral Artery in-Stent Restenosis Treated with Paclitaxel-Coated Balloon Angioplasty - Results of Three-Year Follow-Up.
    Peclat de Oliveira JC; Alvim Fiorelli RK; Rolim Maia Peclat AP; Peclat de Oliveira LM; Oliveira R; Belczac SQ; Almeida RS; Dalio MB; Joviliano EE; Gutfilen B
    Vasc Endovascular Surg; 2023 Oct; 57(7):673-679. PubMed ID: 36945834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-Term Outcomes After Treatment With a Paclitaxel-Coated Balloon Versus Balloon Angioplasty: Insights From the PEPCAD-DES Study (Treatment of Drug-eluting Stent [DES] In-Stent Restenosis With SeQuent Please Paclitaxel-Coated Percutaneous Transluminal Coronary Angioplasty [PTCA] Catheter).
    Rittger H; Waliszewski M; Brachmann J; Hohenforst-Schmidt W; Ohlow M; Brugger A; Thiele H; Birkemeyer R; Kurowski V; Schlundt C; Zimmermann S; Lonke S; von Cranach M; Markovic S; Daniel WG; Achenbach S; Wöhrle J
    JACC Cardiovasc Interv; 2015 Nov; 8(13):1695-700. PubMed ID: 26476609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison between drug-coated balloon angioplasty and second-generation drug-eluting stent placement for the treatment of in-stent restenosis after drug-eluting stent implantation.
    Kang IS; Shehata I; Shin DH; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
    Heart Vessels; 2016 Sep; 31(9):1405-11. PubMed ID: 26337620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Critical appraisal of paclitaxel balloon angioplasty for femoral-popliteal arterial disease.
    Herten M; Torsello GB; Schönefeld E; Stahlhoff S
    Vasc Health Risk Manag; 2016; 12():341-56. PubMed ID: 27621646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug-coated balloon dilation before carotid artery stenting of post-carotid endarterectomy restenosis.
    Piccoli G; Biondi-Zoccai G; Gavrilovic V; Radici V; Cancelli I; Frigatti P; Frati G; Marullo AG; Divis P; Gasparini D
    J Endovasc Ther; 2015 Apr; 22(2):212-6. PubMed ID: 25809364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paclitaxel-Coated Balloon vs Uncoated Balloon Angioplasty for Treatment of In-Stent Restenosis in the Superficial Femoral and Popliteal Arteries: The COPA CABANA Trial.
    Tepe G; Schroeder H; Albrecht T; Reimer P; Diehm N; Baeriswyl JL; Brechtel K; Speck U; Zeller T
    J Endovasc Ther; 2020 Apr; 27(2):276-286. PubMed ID: 32096451
    [No Abstract]   [Full Text] [Related]  

  • 19. Benefits with drug-coated balloon as compared to a conventional revascularization strategy for the treatment of coronary and non-coronary arterial disease: a comprehensive meta-analysis of 45 randomized trials.
    Verdoia M; Negro F; Kedhi E; Suryapranata H; Marcolongo M; De Luca G
    Vascul Pharmacol; 2021 Jun; 138():106859. PubMed ID: 33819672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutting Balloon Combined with Drug-Coated Balloon Angioplasty for the Treatment of In-Stent Restenosis.
    Zheng YC; Lee WC; Fang HY; Chen CJ; Yang CH; Wu CJ; Fang CY
    Int Heart J; 2021 Nov; 62(6):1213-1220. PubMed ID: 34744147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.